Vitamin B12 Cuts Risk for Chemotherapy Hand-Foot Syndrome Oral vitamin B12 halves the rate of moderate-to-severe capecitabine-induced hand-foot syndrome in patients with breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback